Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREDESCI: Beta-blockers to Prevent Decompensation of Cirrhosis
NCT01059396Phase 4Completed
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Jan 2010
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of propranolol, carvedilol in Liver cirrhosis (LC), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Started Jan 2010; status: completed.
02
Drugs
propranololcarvedilol
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT01059396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01059396.